FORTREA HOLDINGS INC. Cash and Cash Equivalents
FORTREA HOLDINGS INC. (FTRE) had Cash and Cash Equivalents of $168.60 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-07-29
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $168.60M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $147.50M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $174.60M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $131.30M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $168.60M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $147.50M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $174.60M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $131.30M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $81.20M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $101.60M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $118.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $105.30M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $126.20M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $92.80M 10-Q · filed 2024-05-24 |
| 2023-12-31 | $108.60M 10-K · filed 2025-03-03 |
| 2023-09-30 | $107.50M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $114.30M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $112.00M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |